Journal Article Summary
The article investigates how unmodified and β-glycerophosphate cross-linked chitosan affects the antifungal activity of clotrimazole, a medication used to treat Candida infections. This research is important due to the increasing prevalence of fungal infections and the growing resistance to conventional antifungal treatments. By exploring the potential of chitosan as a drug carrier that may also enhance the effectiveness of antifungal agents, the study aims to contribute to the development of more effective treatment options for patients suffering from these infections.
The researchers conducted experiments using various formulations of hydrogels containing chitosan and clotrimazole, testing their antifungal activity against different strains of Candida. They found that hydrogels made with unmodified chitosan showed significant antifungal effects, while those with β-glycerophosphate cross-linked chitosan had reduced activity. Additionally, the release profile of clotrimazole from these hydrogels was faster compared to a commercially available product, suggesting that the chitosan formulations could be more effective in delivering the drug to combat fungal infections.
However, the study has limitations, including the need for further research to fully understand the impact of β-glycerophosphate on chitosan's antifungal properties. Patients should be aware that while these new formulations show promise, the effectiveness can vary based on the specific Candida strain and other factors. It is essential for readers to discuss any concerns or questions about antifungal treatments and new delivery systems with their healthcare professionals to ensure safe and effective care.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Szymańska Emilia, Winnicka Katarzyna, Wieczorek Piotr, Sacha Paweł Tomasz, Tryniszewska Elżbieta Anna. Influence of Unmodified and β-Glycerophosphate Cross-Linked Chitosan on Anti-Candida Activity of Clotrimazole in Semi-Solid Delivery Systems. International Journal of Molecular Sciences 2014. DOI: 10.3390/ijms151017765. PMID: 25272230. PMCID: PMC4227188.
Featured Pill Pals Product
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
